A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784)
12/1992
12/30/1992	CN1019668B Quinolone acid derivatives and process for preparing them
12/30/1992	CA2072725A1 Glycopeptides, a process for their preparation and their use
12/29/1992	US5175177 1,2,4-oxadiazolyl-phenoxyalkylisoxazoles and their use as antiviral agents
12/29/1992	US5175165 Antiviral combinations and compounds therefor
12/29/1992	US5174475 Sequential dosing of antifungal and antiinflammatory compositions
12/29/1992	CA2064544A1 Immune cell proliferation inhibitors
12/29/1992	CA1312076C2 Prodrugs of rapamycin
12/29/1992	CA1312013C Compositions and methods for treating gastrointestinal disorders
12/29/1992	CA1312012C Compositions and methods for treating gastrointestinal disorders
12/28/1992	CA2072246A1 Ccv vaccine
12/28/1992	CA2072207A1 7-azaisoindolinyl-quinolone-and-naphthyridonecarboxylic- acid derivatives
12/26/1992	CA2072031A1 Cephalosporins having a 2-thia cephem nucleus, method of preparation, their use as therapeutic agents, pharmaceutical compositions containing them and new intermediaries obtained
12/26/1992	CA2071439A1 2-heteroarylphenyl-carbapenem antibacterial agents
12/24/1992	DE4120327A1 Neue peptide, ihre herstellung und verwendung New peptides, their preparation and use
12/23/1992	WO1992022664A1 Chemotactic factor
12/23/1992	WO1992022641A1 Immunodeficiency virus recombinant poxvirus vaccine
12/23/1992	WO1992022588A1 Acylated heparins as inhibitors of the replication of retroviruses
12/23/1992	WO1992022578A1 Novel polypeptides and their use
12/23/1992	WO1992022577A1 Immunogen compounds having specifically an anti-cytokine effect, method of preparation, pharmaceutical compositions and kits containing them
12/23/1992	WO1992022575A1 M-protein peptides of influenza virus as antiviral agents
12/23/1992	WO1992022570A1 Inhibitors of picornavirus proteases
12/23/1992	WO1992022556A1 Novel 3-fused pyridiniummethyl cephalosporins
12/23/1992	WO1992022550A1 Azaspiro quinolone antibacterial agents
12/23/1992	WO1992022520A1 Orally active antiviral compounds
12/23/1992	WO1992022326A1 Insertional mutations in mycobacteria
12/23/1992	WO1992022317A1 Composition and treatment with biologically active peptides having c-terminal substitutions
12/23/1992	WO1992022308A1 Broad spectrum antimicrobial compounds and methods of use
12/23/1992	WO1992022297A1 New compounds and compositions useful as antifungal and antimycobacterial agents
12/23/1992	EP0519866A1 Novel anti-HIV antibodies
12/23/1992	EP0519726A2 A process for large-scale production of antimicrobial peptide in high purity
12/23/1992	EP0519702A1 Orally active antiviral compounds
12/23/1992	EP0519554A1 Conjugates of the class II protein of the outer membrane of neisseria meningitidis and of HIV-1 related peptides
12/23/1992	EP0519516A1 Penem derivatives
12/23/1992	EP0519463A1 Synthetic, catalytic oligonucleotides
12/23/1992	EP0519433A1 Compounds with renin-inhibiting properties, process for their preparation and their use
12/23/1992	EP0519351A2 Megestrol acetate formulation
12/23/1992	EP0519218A2 Hybrid-plasmid for the 38 kDa antigen from M. tuberculosis, E. coli as host, the 38 kDa antigen and a 33 kDa protein
12/23/1992	EP0519013A1 Peptides stimulating cytotoxic t cells immune to hiv rt
12/23/1992	EP0519001A1 PURIFIED gp120 COMPOSITION RETAINING NATURAL CONFORMATION
12/23/1992	CN1067245A Processes for diastereoselective synthesis of nucleosides
12/23/1992	CN1067244A Pyrrolidones
12/23/1992	CN1019578B Process for preparation of quinolinecarboxylic acid derivatives
12/23/1992	CA2111471A1 Inhibitors of picornavirus proteases
12/23/1992	CA2111459A1 Novel 3-fused pyridiniummethyl cephalosporins
12/23/1992	CA2111338A1 New compounds and compositions useful as antifungal and antimycobacterial agents
12/23/1992	CA2111231A1 Acylated heparins as inhibitors of the replication of retroviruses
12/23/1992	CA2111217A1 Insertional mutations in mycobacteria
12/23/1992	CA2111214A1 Composition and treatment with biologically active peptides having c-terminal substitutions
12/23/1992	CA2110489A1 Immunodeficiency virus recombinant poxvirus vaccine
12/23/1992	CA2108263A1 M-protein peptides of influenza virus as antiviral agents
12/23/1992	CA2071677A1 7-isoindolinyl-quinolone- and -naphthyridonecarboxylic acid derivatives
12/22/1992	WO1993000345A1 Penem derivatives
12/22/1992	WO1993000005A1 Method for inactivating pathogens in a body fluid
12/22/1992	US5173498 Substituted 3-thia- and 3-oxa-alkylflavones, a process for their preparation, the use thereof, medicaments based on these compounds and intermediates
12/22/1992	US5173297 Bacteriocin from lactococcus lactis subspecies lactis
12/22/1992	US5173294 Purified antiserum which recognizes homophilus influenzae outer membrane protein for treating diseases caused by pathogen
12/22/1992	CA2088913A1 Penem derivatives
12/22/1992	CA2071744A1 Compounds with renin-inhibiting properties, a process for the preparation thereof and the use thereof
12/22/1992	CA1311683C Process for the preparation of a composition inhibiting or destructing at least one living unicellulary organism containing quaternary ammonium fluorideand process for the preparation of this salt
12/20/1992	WO1992022310A1 Asialoglycoprotein-conjugated medicinal agent
12/20/1992	CA2089881A1 Asialoglycoprotein-conjugated medicinal agent
12/20/1992	CA2071088A1 Conjugates of the class ii protein of the outer membrane of neisseria meningitidis and of hiv-1 related peptides, and vaccines containing same
12/19/1992	CA2071305A1 Anti-hiv antibodies
12/19/1992	CA2071141A1 Megestrol acetate formulation
12/16/1992	EP0518676A2 Cyclic renin inhibitors
12/16/1992	EP0518675A2 Cyclic renin inhibitors
12/16/1992	EP0518672A2 Cyclic renin inhibitors
12/16/1992	EP0518558A1 1-Methylcarbapenem derivatives, their preparation and their use as antibiotics
12/16/1992	EP0518443A1 Recombinant proteins of viruses associated with lymphadenopathy syndrome and/or acquired immune deficiency syndrome
12/16/1992	EP0517986A1 Transformed erythrocytes, process for preparing the same, and their use in pharmaceutical compositions
12/16/1992	EP0517859A1 Oligonucleotide therapies for modulating the effects of herpesviruses
12/16/1992	EP0517836A1 Method and product for promoting hair growth and treating skin conditions
12/16/1992	EP0517796A1 Oligonucleotide analogs.
12/16/1992	EP0517792A1 Terminally blocked antiviral peptides
12/16/1992	CN1067055A Crystallizing acid addition salt of 3-cephem-4-carboxylic acid-1-(2,2-dimethylpropionyloxy) ethyl ester non-emantiomorph
12/16/1992	CN1019495B Preparation for pyrimidine derivative
12/16/1992	CN1019493B Process for producing cephalsporin derivatives
12/15/1992	WO1992022306A1 Transformed erythrocytes, process for preparing the same, and their use in pharmaceutical compositions
12/15/1992	US5171839 Nucleotide and amino acid sequences of protein mtp40 of m. tuberculosis and synthetic peptides derived therefrom
12/15/1992	US5171836 Bactericides for use aganist methicillin-resistant bacteria
12/15/1992	US5171741 Treating undesired biological target to destroy infected cells or viruses
12/15/1992	US5171739 Treatment of endotoxin-associated shock and preventation thereof using a BPI protein
12/15/1992	US5171580 Orally-pharmaceutical preparations with colon selective delivery
12/15/1992	CA2102619A1 Transformed erythrocytes, process for preparing the same, and their use in pharmaceutical compositions
12/12/1992	WO1992022654A1 Vaccine and treatment method of human immunodeficiency virus infection
12/12/1992	CA2087732A1 Vaccine and treatment method of human immunodeficiency virus infection
12/12/1992	CA2070983A1 Cyclic renin inhibitors
12/12/1992	CA2070978A1 Cyclic renin inhibitors
12/12/1992	CA2070972A1 Cyclic renin inhibitors
12/10/1992	WO1992021758A1 Mycobacterium proteins and applications
12/10/1992	WO1992021751A1 Bovine herpesvirus type 1 deletion mutants, vaccines based thereon, diagnostic kits for detection of bovine herpesvirus type 1
12/10/1992	WO1992021750A1 Eukaryotic expression vectors with regulation of rna processing
12/10/1992	WO1992021692A1 Oligo-2'-deoxynucleotides and their use as drugs with an antiviral action
12/10/1992	WO1992021691A1 2',5'-nucleotide analogs as antiviral agents
12/10/1992	WO1992021683A1 New cephem compounds
12/10/1992	WO1992021676A1 Crystalline oxathiolane derivatives
12/10/1992	WO1992021659A1 Pyridonecarboxylic acid derivative
12/10/1992	WO1992021647A1 Carbocyclic and heterocyclic hiv protease inhibitors
12/10/1992	WO1992021377A1 Peptides for use in induction of t cell activation against hiv-1
12/10/1992	WO1992021362A1 Nerve growth factor for use in the prevention and treatment of viral infections

1 ... 1678 1679 1680 1681 1682 1683 1684 1685 1686 1687 1688 1689 1690 1691 1692 1693 1694 1695 1696 1697 1698 ... 1798